Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Sep 07, 2021 8:45 AM - Sep 07, 2021 5:00 PM

(Singapore Standard Time)

DIA Asia 2021-The Evolution Of Clinical Trials And Regulatory Science In A Post-Pandemic Digital World In Asia

The timing is as per Singapore Time Zone

Opening Plenary : Bio-venture / Mega-pharma Building Ecosystems In Asia

Session Chair(s)

Junko  Sato, PhD

Junko Sato, PhD

Associate Executive Director

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Jing Ping  Yeo, PhD

Jing Ping Yeo, PhD

Head - Transformation

George Clinical, Singapore

The growth potential of Asia pharmaceutical and life science industries is astounding over the past few years and this sector is poised for growth. Despite Asia being a collection of markets with very diverse sets of regulatory environments, demographics, economic impact and disease profiles, Asia eco-system is investing in its capabilities to advance patient centricity and expectations of healthcare and life science experience. The scientific and technological developments in cell and gene therapies, mRNA, digital analytics capabilities, patient centric delivery, smart health devices are changing the current business models and driving cross-sector economy. In this plenary, we will review how the bioventures, mega pharmas, small startups collaborate with governments and regulators to build an innovative and sustainable ecosystem, so as to support the transformation into a patient centric, valued focused research landscape.

Speaker(s)

Danny  Soon

Bio-venture / mega-pharma building ecosystems in Asia: Danny Soon

Chief Executive Officer, CRIS, Executive Director, SCRI, Interim Executive

Director, ACTRIS, Singapore

Danny  Soon

Panel Discussion: Danny Soon

Chief Executive Officer, CRIS, Executive Director, SCRI, Interim Executive

Director, ACTRIS, Singapore

Timothy  Low

Participating Panelist: Timothy Low

Head of Healthcare Investment

Pavilion Capital International Pte Ltd, Singapore

Celine   Ting

Participating Panelist: Celine Ting

Managing Director

Eisai (Singapore) Pte Ltd, Singapore

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.